Rite Aid Corp. | StockChase
23
Rite Aid Corp. (RAD-N)

Last Price Recorded: $1.5400 on 2017-11-16

ON STOCKCHASE SINCE Feb 2002

specialty stores

Rite Aid Corp.


Signal Opinion Expert

2017-09-19

DON'T BUY
Rite Aid Corp. (RAD-N)

The deal to be acquired by Walgreens (WBA-Q) didn’t get off the ground. There were some antitrust issues. However, they struck a deal to buy individual stores. It is going to take Walgreens from about 8000 stores to about 10,000, which will compete pretty much head-to-head with CVS (CVS-N). These stores are not as efficient and need some work. Also the company needs some capital, because they need to improve their offering.

specialty stores
Gordon Reid

President, GoodReid Investment Counsel

Price: $2.400
Owned: No

2017-08-03

HOLD
Rite Aid Corp. (RAD-N)

Doesn’t think there is really an issue with this stock. Pharmacies haven’t quite been where the action is in the healthcare vertical. This is a decent name.

specialty stores
John Stephenson

President & CEO, Stephenson & Company Capital Management

Price: $2.390
Owned: Unknown

2017-01-25

PAST TOP PICK
Rite Aid Corp. (RAD-N)

(A Top Pick Oct 11/16. Down 3.59%.) This was and is subject to a takeover offer by Walgreens. Sold his holdings at about $8.30.

specialty stores
Dean Orrico

President, Middlefield Capital Corp.

Price: $6.900
Owned: No

2016-10-11

TOP PICK
Rite Aid Corp. (RAD-N)

About a year ago, Walgreen Boots Alliance (WBA-Q) wanted to take this over in a friendly deal, at $9. For the better part of 9 months, the stock didn’t move. There have been a number of M&A transactions in the healthcare space that didn’t work out, so all the risk arbitrage players who were focused on healthcare weren’t playing it. He is sure this is a transaction that is going to happen, which would give you a 20% lift.

specialty stores
Dean Orrico

President, Middlefield Capital Corp.

Price: $7.370
Owned: Yes

2016-06-22

COMMENT
Rite Aid Corp. (RAD-N)

He doesn’t cover this, because as a pharmacy it is considered a consumer staple. Right now this is being subject to a takeover by Walgreen Boots Alliance (WBA-Q).

specialty stores
Paul Macdonald

Chief Investment Officer & Portfolio Manager, Harvest Portfolios Group

Price: $7.730
Owned: No

2016-03-02

COMMENT
Rite Aid Corp. (RAD-N)

This has been the “sick man” of the pharmacy business. It is now dominated by CVS and the Walgreen conglomerate, and there would be serious anti-trust concerns if one of those 2 bought this company. A great sector to be in.

specialty stores
David Baskin

President, Baskin Wealth Management

Price: $7.970
Owned: Unknown

2015-12-15

DON'T BUY
Rite Aid Corp. (RAD-N)

Pharmacy stocks are defensive holdings overall. The best time from a seasonal perspective, is really when everybody else is perturbed by the market, which is in the summer months. He wouldn’t be investing in this right now. Chart shows this is still in a downward trend.

specialty stores
Brooke Thackray

President, Jov Investment Management

Price: $7.800
Owned: No

2015-09-22

DON'T BUY
Rite Aid Corp. (RAD-N)

The type of company that tends to hold in pretty well in weak markets. Weak markets are where you can get good companies that haven’t held in well and don’t seem all that safe. There are other places that he would go to, but in a different sector.

specialty stores
Bruce Tatters

Founding Partner and CIO, Triumph Asset Management

Price: $7.170
Owned: No

2015-09-17

DON'T BUY
Rite Aid Corp. (RAD-N)

Just announced that some of their earnings are going to be rough going forward. He prefers CVS Health (CVS-N). Rite Aid has been beaten up quite a bit.

specialty stores
Stan Wong

Director & Portfolio Manager, Private Wealth Management, ScotiaMcleod

Price: $7.660
Owned: No

2015-08-28

DON'T BUY
Rite Aid Corp. (RAD-N)

Thinks the turnaround has been completed. They are now profitable again, not hugely so, but thinks they have turned the corner. The stock has rebounded dramatically from its lows. This is the 3rd biggest player in its group and he doesn’t see how you would want to pay 25X earnings for this, compared to 17 to 20 times earnings for CVS (CVS-N) or Walgreen’s (WBA-Q), which have a lot more going for them. Good sector.

specialty stores
Don Lato

President, Padlock Investment Management

Price: $8.240
Owned: Unknown

2014-10-08

HOLD
Rite Aid Corp. (RAD-N)

Looked at this when it was around $2. Didn’t like the salaries of managers. Had a big debt load. This is still on his Watch List and he is watching for further weakness in the sector. A good sector to be in because drug companies are tremendous at marketing people.

specialty stores
Benj Gallander

President, Contra the Heard Investment Letter

Price: $5.010
Owned: No

2014-09-30

DON'T BUY
Rite Aid Corp. (RAD-N)

Has Walgreen and CVS.  This is the poor cousin.  They had a tough with input costs and the stock was hurt badly.  It will probably recover, but when you can buy the other two, just go with them.  This one is more speculative.

specialty stores
Gordon Reid

President, GoodReid Investment Counsel

Price: $4.840
Owned: No

2014-03-17

COMMENT
Rite Aid Corp. (RAD-N)

The poor relative to Walgreen (WAG-N). Has done really well in the last year or so but that is from a flirtation with bankruptcy. It is remarkable how some of the major retail chains in the US are in a very difficult, long-term position with the growth of ordering over the Internet. He would prefer to be with the leader Walgreen rather than being in the number 2 position.

specialty stores
Gavin Graham

Trustee, Pointbreak ETFs

Price: $6.870
Owned: Unknown

2009-04-27

DON'T BUY
Rite Aid Corp. (RAD-N)
This is not the right time to be a credit-constrained company. Good competition.
specialty stores
Gavin Graham

Trustee, Pointbreak ETFs

Price: $0.950
Owned: Unknown

2008-09-10

DON'T BUY
Rite Aid Corp. (RAD-N)
(Market Call Minute.) The most levered of the drugstores. Would go to Walgreen (WAG-N) instead.
specialty stores
Pat Naccarato

Vice President and Portfolio Manager, AIC Limited

Price: $1.000
Owned: Unknown

Showing 1 to 15 of 23 entries
<< < 1 2 > >>

No Comments.


You must be logged in to comment.